to experience the full functionality of mail.com.
Enhanced by Google
July 21, 2016
Hawaii health agency faces challenge in Hepatitis A outbreak
Frustrated Hawaii health officials say they have faced a number of challenges trying to identify the source of a hepatitis ...
June 28, 2016
FDA approves first pill to treat all forms of hepatitis C
Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series ...
May 05, 2016
Merck beats 1Q profit views with tight cost controls
Merck posted an 18 percent jump in first-quarter income, beating Wall Street expectations, as reduced spending on marketing, ...
April 28, 2016
Gilead 1Q profit tumbles on slower hepatitis C drug sales
Gilead Science Inc.'s earnings tumbled more than 17 percent in the first quarter as steeper discounts and rebates on its ...
April 14, 2016
New tests for choosing right hep C drug could save money
New tests designed to help doctors pick the right hepatitis C medicine for patients could mean faster cures and lower costs.
April 11, 2016
Overstock.com's CEO takes medical leave
Overstock.com Inc.'s founder and CEO, Patrick M. Byrne, said he will take a personal leave of absence for medical reasons.
April 04, 2016
Gilead paying up to $1.2B for Nimbus unit, drug candidate
Biologic drugmaker Gilead Sciences Inc. said Monday that it will buy a subsidiary of Nimbus Therapeutics LLC and its ...
March 25, 2016
Jury: Gilead owes Merck $200M in damages over drug patents
The federal jury in a patent trial has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing ...
March 22, 2016
Jury finds for Merck in hepatitis drug fight with Gilead
A federal jury in California has ruled in favor of drugmaker Merck & Co. in a high-stakes lawsuit against rival Gilead ...
March 09, 2016
James Deen porn company cited for failing to use condoms
California regulators on Wednesday cited a movie company owned by porn star James Deen for failing to use condoms on a film ...
February 03, 2016
Merck beats 4Q profit forecast, misses Street view on sales
Merck & Co. posted an 87 percent drop in fourth-quarter profit compared with last year, when the drugmaker had a huge gain ...
January 28, 2016
FDA OKs Merck hepatitis C drug, adding to patient choices
Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday ...
January 27, 2016
Massachusetts is investigating high cost of hepatitis C drug
The Massachusetts attorney general's office said Wednesday that it is investigating whether the makers of a breakthrough ...